CLEVELAND--(BUSINESS WIRE)--Hitachi Medical Systems America, Inc., a leading provider of diagnostic imaging equipment, announced FDA clearance to market its SCENARIA CT system, the latest in the company’s line of CT products. SCENARIA combines the latest dose saving technologies in a new 64-slice platform that meets today’s need for a CT system that provides both routine and advanced applications with enhanced performance and value.
“SCENARIA includes a complete suite of dose reduction and awareness features, including Intelli IP™ Iterative Reconstruction, to enable high quality lower dose scanning across the full range of applications for Adult and Pediatric patients.”
“SCENARIA is another example of Hitachi’s ability to provide a superior product by combining the latest dose saving and imaging technologies with unparalleled ergonomic benefits afforded by a slimmer gantry design with wider 75cm aperture and a lateral shifting table,” said Mark Silverman, Manager of CT Marketing. “SCENARIA includes a complete suite of dose reduction and awareness features, including Intelli IP™ Iterative Reconstruction, to enable high quality lower dose scanning across the full range of applications for Adult and Pediatric patients.”
“With more than 68 Million CT procedures ordered across the US in 2009, it is important for CT to continue to achieve the good benefits of its diagnostic potential while further reducing patient radiation risk. SCENARIA, with its array of prescient technologies is an important tool for enhancing these benefits and reducing the radiation risk of CT Exams,” said Sheldon Schaffer, Vice President and General Manager, MR and CT.
source: Business Wire
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment